ArticleEMBO reports2026
Visual system function requires translational regulation of ATF4 by Hbs1-Pelo.
Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
7 authors.
Funding
Abstract
Deletion mutations in the translation termination factor HBS1L result in progressive loss of vision in human patients, amongst other developmental anomalies. The etiology of vision defects seen with HBS1L deletion remains unknown. Here, we use the Drosophila visual system to demonstrate that the HBS1L ortholog, Hbs1, and its interaction partner, Pelo, are required for proper phototransduction. Hbs1 mutants showed 'vacuolization' of the lamina layer, indicative of defective synapse transmission between photoreceptors and lamina neurons. Depleting Hbs1 in lamina neurons replicated the phototransduction defects seen in Hbs1 mutants, suggesting that Hbs1-Pelo is required for proper lamina neuron function. Mechanistically, we found that loss of HBS1L in both Drosophila and cultured human cells results in reduced levels of the stress responsive Activating Transcription Factor 4 (ATF4). Strikingly, restoring ATF4 expression in the lamina partially rescues ERG defects in Hbs1 mutants, indicating that ATF4 is likely a relevant mRNA target regulated by Hbs1-Pelo in these cells. Together, we propose a model wherein Hbs1-Pelo-mediated translation regulation of ATF4 in lamina neurons underlies the inherited retinal disease caused by HBS1L deletion.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.